Significantly reduced docosahexaenoic and docosapentaenoic acid concentrations in erythrocyte membranes from schizophrenic patients compared with a carefully matched control group

Biological Psychiatry

Volumn 49, Issue 6, 2001, Pages 510-522

  Assies, Johanna ^a,b   Lieverse, Ritsaert ^a   Vreken, Peter ^a   Wanders, Ron J A ^a   Dingemans, Peter M J A ^a   Linszen, Donald H ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b Departments of Psychiatry and Internal Medicine   (Netherlands)

Author keywords

Diet; Fatty acids; Hormones; Membrane; Recent onset; Schizophrenia

Indexed keywords

ARACHIDONIC ACID; BIPERIDEN; CANNABIS; CHLORPROMAZINE; CLOZAPINE; DEXETIMIDE; DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; FLUVOXAMINE; HORMONE; LITHIUM CARBONATE; MEMBRANE PHOSPHOLIPID; OLANZAPINE; OXAZEPAM; PAROXETINE; PIMOZIDE; RISPERIDONE; SATURATED FATTY ACID; TEMAZEPAM; TRIHEXYPHENIDYL;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEPRESSION; DIET; ERYTHROCYTE MEMBRANE; FATTY ACID BLOOD LEVEL; FATTY ACID METABOLISM; FEMALE; HORMONE BLOOD LEVEL; HUMAN; HUMAN CELL; LIPID COMPOSITION; MALE; MENTAL PATIENT; NEGATIVE SYNDROME; PHOSPHOLIPID METABOLISM; PRIORITY JOURNAL; RATING SCALE; SCHIZOPHRENIA;

ADOLESCENT; ADULT; CHROMATOGRAPHY, GAS; DOCOSAHEXAENOIC ACIDS; ENERGY INTAKE; ERYTHROCYTE MEMBRANE; FATTY ACIDS, UNSATURATED; FEMALE; FOLLOW-UP STUDIES; HORMONES; HUMANS; MALE; NUTRITIONAL STATUS; QUESTIONNAIRES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0035869237     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(00)00986-0     Document Type: Article

References (84)

1. Cannabis: Pharmacology and toxicology in animals and humans
2. Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression
3. HPA-axis and cytokine dysregulation in schizophrenia: Potential implications for the antipsychotic treatment
4. Docosahexaenoic acid is the preferred dietary ω-3 fatty acid for the development of the brain and retina
5. Nervonic acid in red blood cell sphingomyelin in premature infants: An index of myelin maturation?
6. Structural and functional importance of dietary polyunsaturated fatty acids in the nervous system
7. The effects of dietary alpha-linolenic acid on the composition of nerve membranes, enzymatic activity, amplitude of electrophysiological parameters, resistance to poisons and performance of learning in rats
8. Dietary alpha-linolenic acid at 1,3 g/kg maintains maximal docosahexaenoic acid concentrations in brain, heart and liver of adult rats
9. Nutritional and hormonal factors influencing desaturation of essential fatty acids
10. High fat diets varying ratios of polyunsaturated to saturated fatty acids and linolenic acid, a comparison of rat neural and red cell membrane phospholipids
11. Fat consumption and schizophrenia
12. The fatty acid elongation system of mammalian endoplasmatic reticulum
13. Is the docosahexaenoic acid (DHA 22:6.ω-3) content of erythrocytes a marker for the DHA content of brain phospholipids?
14. Measurement of very long-chain fatty acids, phytanic and pristanic acid in plasma and cultured fibroblasts by gas chromatography
15. Essential fatty acids modulate apomorphine activity at dopamine receptors in cat caudate slices
16. Enzymatic pathways of phospholipid metabolism in the nervous system
17. Chronic dietary alpha-linolenic acid deficiency alters dopaminergic and serotonergic neurotransmission in rats
18. Peroxisome proliferator-activated receptors: Nuclear control of metabolism
19. Red cell membrane fatty acids, cytosolic phospholipase-A2 and schizophrenia
20. Towards a Cannabinoid hypothesis of schizophrenia: Cognitive impairments due to dysregulation of the endogenous cannabinoid system
21. Dietary omega-3 polyunsaturated fatty acids reduce IFN-gamma receptor expression in mice
22. Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia
23. Effects of dietary fatty acids on the fatty acid composition of brain ethanolamine phosphoglyceride: Reciprocal replacement of n-6 and n-3 polyunsaturated acids
24. Membrane fatty acids, niacin flushing and clinical parameters
25. A red cell membrane abnormality in a subgroup of schizophrenic patients: Evidence for two diseases
26. Regulation of the metabolism of polyunsaturated fatty acids
27. Dietary polyunsaturated fatty acids and depression: When cholesterol does not satisfy
28. Membrane abnormalities in the psychoses and affective disorders
29. Human essential fatty acid deficiencies of dietary and metabolism origin
30. Possible relevance of phospholipid and genetic interactions in psychiatric disorders: The relationship between dyslexia and schizophrenia
31. The membrane hypothesis of schizophrenia
32. Fatty acid levels in the brains of schizophrenics and normal controls
33. Essential fatty acids in growth and development
34. The triggering signal dictates the effect of docosahexaenoic acid on lymphocyte function in vitro
35. Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue: An 18 month controlled study
36. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia
37. Lipids, membrane receptors, and enzymes: Effects of dietary fatty acids
38. Fatty acids and schizophrenia
39. Essential fatty acid deficiencies in parentally fed preterm infants
40. Cannabis abuse and the course of recent-onset schizophrenia
41. Lowered ω3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients
42. Acute phase proteins in schizophrenia, mania and major depression: Modulation by psychotropic drugs
43. Fatty acid composition in major depression: Decreased omega3 fractions in cholesteryl esters and increased C20:4 omega6/C20:5 omega 3 ratio in cholesteryl esters and phospholipids
44. Fatty acids, cytokines, and major depression
45. Plasma membrane phospholipid fatty acid composition of cultured skin fibroblasts from schizophrenic patients: Comparison with bipolar patients and normal subjects
46. Utilization of precursor essential fatty acids in culture by skin fibroblasts from schizophrenic patients and normal controls
47. Effect of in vivo modulation of membrane docosahexaenoic acid levels on the dopamine-dependent adenylate cyclase activity in the rat retina
48. Trifluoperazine increases fatty acid turnover in phospholipids of cultured human fibroblasts
49. Potentiation of NMDA receptor currents by arachidonic acid
50. A new depression scale designed to be sensitive to change
51. A neurodevelopmental approach to the classification of schizophrenia
52. Functional modulation of human recombinant gamma-aminobutyric acid type A receptor by docosahexaenoic acid
53. Fatty acid profiles in mental disease, linolenate variations in schizophrenia
54. Dietary fatty acids - The n-6/n-3 balance and chronic elderly diseases: Excess linolenic acid and relative n-3 deficiency syndrome seen in Japan
55. Serotonin-induced endothelial cell proliferation is blocked by omega-3 fatty acids
56. The effects of cigarette smoking on the metabolism of essential fatty acids
57. Depleted red cell membrane essential fatty acids in drug-treated schizophrenic patients
58. Essential fatty acid deficiency in erythrocyte membranes from chronic schizophrenic patients, and the clinical effects of dietary supplementation
59. Depletion of omega-3 fatty acid levels in red blood cell membrane of depressive patients
60. Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first episode drug-naive schizophrenics
61. Antipsychotics
62. Dopamine activation of the arachidonic acid cascade as a basis for D1-D2 receptor synergism
63. Sustained remission of positive and negative symptoms of schizophrenia following treatment with eicosapentaenoic acid
64. Hypothyroidism and thyroxin substitution affect the ω-3 fatty acid composition of rat liver mitochondria
65. Increased phopholipid breakdown in schizophrenia, evidence for the involvement of a calcium-independent phopholipase A2
66. Differential alteration of phospholipase A2 in brain of patients with schizophrenia
67. Phospholipid and prostaglandin hypotheses of schizophrenia
68. Docosahexaenoic acid membrane function and metabolism
69. The nervous system has an absolute molecular species requirement for proper function
70. Nervonic acid and demyelinating disease
71. An in vivo study of the prefrontal cortex of schizophrenic patients at different stages of illness via phosphorus magnetic resonance spectroscopy
72. The distribution of the phospholipid fractions in the red blood cell membrane of schizophrenics
73. Effects of neuroleptics on the lipid peroxidation and peroxide metabolism enzyme activities in various discrete areas of the rat brain
74. Recent advances in the biochemistry and molecular biology of fatty acyl desaturases
75. Schizophrenia, tardive dyskinesia and essential fatty acids
76. Lipids and schizophrenia
77. Effect of long-chain polyunsaturated fatty acids in infant formula on problem solving
78. Arachidonic acid induces a long-term activity dependent enhancement of synaptic transmission in the hippocampus
79. Red blood cell membrane dynamics in schizophrenia. II. Fatty acid composition
80. Membrane phospholipid abnormalities in postmortem brains from schizophrenic patients
81. Fatty acids and brain peptides